Diagnosis & Management
Recent studies have shown that when vasa praevia is prenatally diagnosed, and a proper management plan is followed, the infant survival rate (absent any other congenital defect) is ~100%.
- Diagnosis is made by ultrasound using colour Doppler (see What is colour Doppler ultrasound?)
- During any anomaly scan the position of the placenta and the placental insertion of the umbilical cord should be recorded (i.e. whether the cord is centrally inserted, marginally inserted, a velamentous insertion or vasa praevia etc.).
- In all cases where the placenta is low lying and/or the where the insertion of the umbilical cord is not central these cases must be referred for further diagnostic testing.
- Additionally, all women presenting with warning signs or within the risk groups (see Women in risk groups) should be scanned using transvaginal colour Doppler ultrasound again to specifically locate the placental-umbilical cord connection (see algorithm below).
- If you suspect vasa praevia and you are not proficient in the use of colour Doppler ultrasound you should refer the patient to someone suitably qualified to make the diagnosis (see – What Next?)
The Royal College of Obstetricians and Gynaecologists have recently announced that they will be amending the current guidelines on the diagnosis and management of placenta praevia and placenta praevia accreta to specifically include advice on the diagnosis and recommendations of vasa praevia.
Why should colour doppler be used?



Source: www.thefetus.net
This is an artery with an interior velamentous insertion. Note on the greyscale there is no evidence of vasa praevia, but as the scan progresses to colour and the power doppler it is clear there is vasa praevia.
Again, there is no reason not to use colour doppler during these examinations. The diagnosis would have been missed otherwise.
Diagnostic Algorithm
The following diagnostic algorithm was proposed by Philippe Jeanty MD. PhD, to the Fetal Medicine Foundation 6th World Congress in Fetal Medicine (June 2007):
[NB. In a study soon to be published over 93% of all clinicians surveyed at the FMF 6th World Congress indicated that they would adopt this algorithm as a routine practice]
Diagnostic Algorithm for the diagnosis of Vasa Praevia courtesy and © 2007 of www.thefetus.net
2024 The International Consensus Statements re the diagnosis, definition & screening of Vasa Praevia
In 2024 57 leading experts reached a consensus on the following statements, re the Definition & Screening of Vasa Praevia (see https://pubmed.ncbi.nlm.nih.gov/38494071/ for the full paper)
| Definition |
| •In my routine practice, I make the diagnosis of VP at any gestational age, but it should be confirmed later in the pregnancy. •The diagnosis of VP made in the second trimester should be confirmed during the third trimester or before delivery. •Although there is no consensus regarding a definition for VP based on distance from the internal os, I feel the definition of VP should not be limited to vessels within 2 cm of the internal os. |
| Screening |
| •I recommend screening for VP in all pregnant persons. •I recommend screening at the time of the anatomy scan. •I recommend a follow-up transvaginal sonography/color Doppler imaging at approximately 32 wk in patients with a previous diagnosis of placenta previa, low-lying placenta, or VP at the time of anomaly scan. •I recommend routine identification of the umbilical cord insertion into the placenta by transabdominal ultrasound at the time of the mid-trimester anatomy scan in all pregnant individuals. •In all pregnant individuals, including those without risk factors, I recommend routine transabdominal ultrasound with color Doppler sweep of the lower uterine segment. •I recommend that when VP is suspected on transabdominal ultrasound, the diagnosis be confirmed with transvaginal ultrasound with Doppler. •In pregnant persons with any risk factors, I recommend routine screening with transvaginal sonography and color Doppler imaging for VP. •In the evaluation of suspected VP by transvaginal sonography/color Doppler imaging, I recommend examining the region over the cervix in multiple planes (ie, sagittal, coronal, etc.). •During the evaluation for suspected VP, whenever possible, the fetal presenting part should not be applied on the cervix to avoid compressing the vessels. Techniques such as manual displacement or positioning the patient in a Trendelenburg position may be used to achieve this. |
2024 The International Consensus Statements re Management & Monitoring of Vasa Praevia, and Timing of Delivery
In 2024 the 57 leading experts also reached a consensus on the following statements regarding the appropriate management of Vasa Praevia (see https://pubmed.ncbi.nlm.nih.gov/38494071/ for the full paper).
| Management and monitoring |
| •I recommend admission to VP patients with variable decelerations on the outpatient NST/CTG.•I recommend admission to VP patients with bleeding or rupture of membranes. •I offer admission according to the special social circumstances of the pregnant person (including their willingness to become admitted, their anxiety, difficult access to the medical center, etc.). •I recommend admission to patients with progressive cervical shortening in the third trimester. •I recommend admission to patients with premature symptomatic uterine contractions. •I offer/recommend admission to patients with limited access to medical centers in the third trimester. •Transvaginal ultrasound measurements of cervical length have a role in the management of VP. This may be individualized according to institutional protocols and resources.•In patients with VP, fetal surveillance, including biophysical profile examinations and growth scans, plays a role in management and should be conducted in accordance with institutional protocols and available resources. •In asymptomatic patients without risk factors for preterm birth or rupture of membranes, outpatient management is reasonable after appropriate counseling, if the patient desires this, and has easy access to the hospital. •I do not recommend complete bed rest for patients with VP. •I believe that fetoscopic laser ablation for VP should be considered experimental and is not routinely recommended. |
| Time of delivery |
| •I do not recommend routine delivery earlier than 34+0 wk. •I do not recommend delivery later than 38+0 wk. •In asymptomatic patients with VP and a normal cervical length, I recommend routine delivery between 35+0 and 36+6 wk. |

